Literature DB >> 20156530

Herbal drugs: standards and regulation.

Niharika Sahoo1, Padmavati Manchikanti, Satyahari Dey.   

Abstract

The use of herbal drugs for the prevention and treatment of various health ailments has been in practice from time immemorial. Generally it is believed that the risk associated with herbal drugs is very less, but reports on serious reactions are indicating to the need for development of effective marker systems for isolation and identification of the individual components. Standards for herbal drugs are being developed worldwide but as yet there is no common consensus as to how these should be adopted. Standardization, stability and quality control for herbal drugs are feasible, but difficult to accomplish. Further, the regulation of these drugs is not uniform across countries. There are variations in the methods used across medicine systems and countries in achieving stability and quality control. The present study attempts to identify the evolution of technical standards in manufacturing and the regulatory guideline development for commercialization of herbal drugs. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20156530     DOI: 10.1016/j.fitote.2010.02.001

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  46 in total

1.  Herbal drug regulation and commercialization: an Indian industry perspective.

Authors:  Niharika Sahoo; Padmavati Manchikanti
Journal:  J Altern Complement Med       Date:  2013-07-05       Impact factor: 2.579

Review 2.  Recommendations for the development of regulatory guidelines for registration of traditional medicines in South Africa.

Authors:  M Ngcobo; B Nkala; I Moodley; N Gqaleni
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-10-02

Review 3.  Overview of the quality standard research of traditional Chinese medicine.

Authors:  Huimin Gao; Zhimin Wang; Yujuan Li; Zhongzhi Qian
Journal:  Front Med       Date:  2011-06-22       Impact factor: 4.592

Review 4.  Review of the regulations for clinical research in herbal medicines in USA.

Authors:  Tony Yuqi Tang; Fang-Zhou Li; Janyne Afseth
Journal:  Chin J Integr Med       Date:  2014-11-27       Impact factor: 1.978

5.  Assessing the Health Risk and the Metal Content of Thirty-Four Plant Essential Oils Using the ICP-MS Technique.

Authors:  Andreea Maria Iordache; Constantin Nechita; Cezara Voica; Carmen Roba; Oana Romina Botoran; Roxana Elena Ionete
Journal:  Nutrients       Date:  2022-06-07       Impact factor: 6.706

6.  Deep sequencing of plant and animal DNA contained within traditional Chinese medicines reveals legality issues and health safety concerns.

Authors:  Megan L Coghlan; James Haile; Jayne Houston; Dáithí C Murray; Nicole E White; Paula Moolhuijzen; Matthew I Bellgard; Michael Bunce
Journal:  PLoS Genet       Date:  2012-04-12       Impact factor: 5.917

7.  Acute and sub-acute oral toxicity Lagerstroemia speciosa in Sprague-Dawley rats.

Authors:  Saad Alkahtani; Md Saquib Hasnain; Hamzah Algamdy; Nada H Aljarba; Abdullah AlKahtane
Journal:  Saudi J Biol Sci       Date:  2021-11-11       Impact factor: 4.219

8.  Determination of heavy metals concentration in traditional herbs commonly consumed in the United Arab Emirates.

Authors:  Rania Dghaim; Safa Al Khatib; Husna Rasool; Munawwar Ali Khan
Journal:  J Environ Public Health       Date:  2015-04-27

9.  Antinociceptive, muscle relaxant and sedative activities of gold nanoparticles generated by methanolic extract of Euphorbia milii.

Authors:  Nazar Ul Islam; Ibrahim Khan; Abdur Rauf; Naveed Muhammad; Muhammad Shahid; Mohammad Raza Shah
Journal:  BMC Complement Altern Med       Date:  2015-05-29       Impact factor: 3.659

10.  Biophytum sensitivum: Ancient medicine, modern targets.

Authors:  K M Sakthivel; C Guruvayoorappan
Journal:  J Adv Pharm Technol Res       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.